£70.00

It has never been this cheap. We have no record of a lower price.

£70 today · cheaper than every other day in the last 3 months

OmniScriptum Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 67 days · 67 data points (no recent data)

Historical
Generating forecast…
£70.00 £66.50 £67.90 £69.30 £70.70 £72.10 £73.50 26 July 2026 11 August 2026 28 August 2026 13 September 2026 30 September 2026
View at Amazon ↗

Price data last checked 24 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 67 days • 1 price levels

Days at Price
67 days 0 17 34 50 67 £70 Days at Price

Price Analysis

Most common price: £70 (67 days, 100.0%)

Price range: £70 - £70

Price levels: 1 different prices over 67 days

Description

La migraine est la céphalée primaire la plus fréquente. Elle touche en moyenne 12 % de la population et se caractérise par des crises récurrentes de céphalées. Bien que bénigne, elle a un impact non négligeable sur la qualité de vie du fait de la fréquence et de l'intensité des crises. De plus, ces crises ne sont pas toujours faciles à traiter, malgré l'existence de nombreux traitements, des traitements de crise et des traitements de fond. Cependant, certains d'entre eux sont utilisés alors que presque aucun essai clinique n'a été réalisé ou n'a montré leur efficacité. Un bilan est donc nécessaire. C'est pourquoi, ce travail a analysé les différents essais cliniques randomisés, en double aveugle, contre placebo, trouvés dans la littérature. Il permet de faire le point sur les traitements existants, leur efficacité ainsi que leur tolérance.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 June 2011
Listed Since
27 June 2011

Barcode

No barcode data available

Similar Products You Might Like

The 2023-2028 Outlook for Anti-Migraine Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Migraine Drugs in the United States

£520.00 22 Aug 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in China
97% match

The 2023-2028 Outlook for Anti-Migraine Drugs in China

£495.00 19 Aug 2026
The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East
97% match

The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East

£325.00 19 Aug 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
97% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£162.90 02 Oct 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Europe
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Europe

£425.00 24 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America

£425.00 22 Aug 2026
Céphalées de tension et migraines: Rôle de la kinésithérapie et de la relaxation dans le traitement des céphalées de tension et des migraines chez l'adulte (Omn.Univ.Europ.)
97% match

Céphalées de tension et migraines: Rôle de la kinésithérapie et de la relaxation dans le traitement des céphalées de tension et des migraines chez l'adulte (Omn.Univ.Europ.)

OmniScriptum

£81.00 22 Sep 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in Japan
97% match

The 2023-2028 Outlook for Anti-Migraine Drugs in Japan

£495.00 12 Aug 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in India
97% match

The 2023-2028 Outlook for Anti-Migraine Drugs in India

£515.00 24 Aug 2026
Migraine and Headache Disorders: Global Perspective - SDG3
97% match

Migraine and Headache Disorders: Global Perspective - SDG3

Springer

£95.74 25 Sep 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Asia
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Asia

£425.00 21 Aug 2026
Migraine Biology, Diagnosis, and Co-Morbidities (Volume 198) (Handbook of Clinical Neurology, Volume 198)
97% match

Migraine Biology, Diagnosis, and Co-Morbidities (Volume 198) (Handbook of Clinical Neurology, Volume 198)

Elsevier

£177.29 19 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in North America & the Caribbean
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in North America & the Caribbean

£425.00 20 Aug 2026
Interventional Management of Migraines and Headache Disorders Book
97% match

Interventional Management of Migraines and Headache Disorders Book

Elsevier

£119.49 02 Oct 2026
The 2021-2026 World Outlook for Anti-Migraine Drugs
97% match

The 2021-2026 World Outlook for Anti-Migraine Drugs

£795.00 24 Aug 2026
The 2013-2018 Outlook for Anti-Migraine Drugs in Africa
97% match

The 2013-2018 Outlook for Anti-Migraine Drugs in Africa

£325.00 14 Aug 2026
Migraine, Words and Fiction
97% match

Migraine, Words and Fiction

Cambridge Scholars Publishing

£67.99 23 Sep 2026
The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
97% match

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

£795.00 22 Aug 2026
The 2025-2030 World Outlook for Anti-Migraine Drugs
97% match

The 2025-2030 World Outlook for Anti-Migraine Drugs

Price unavailable
Migraine
97% match

Migraine

IntechOpen

£118.98 12 Sep 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana

£425.00 26 Sep 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Africa & the Middle East
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Africa & the Middle East

£425.00 20 Aug 2026
The Biochemistry of Migraine
97% match

The Biochemistry of Migraine

Springer

£158.11 19 Sep 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in the United States
97% match

The 2016-2021 Outlook for Anti-Migraine Drugs in the United States

£595.00 21 Aug 2026